Compounds > lysine
Page last updated: 2024-08-17

lysine and Vestibular Diseases

lysine has been researched along with Vestibular Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Bodamer, O; Choi, J; Hung, C; Jung, YL; Lee, EA1
Hata, K; Iwasaki, Y; Kamura, H; Kawai, T; Nakabayashi, K; Nakamura, K; Ogata-Kawata, H; Takano, T1
Ge, K; Magnuson, T; Shpargel, KB; Starmer, J; Wang, C1
Hirsch, JC; Peusner, KD; Reddaway, R; Shao, M1

Other Studies

4 other study(ies) available for lysine and Vestibular Diseases

ArticleYear
Characterizing the molecular impact of KMT2D variants on the epigenetic and transcriptional landscapes in Kabuki syndrome.
    Human molecular genetics, 2023, 06-19, Volume: 32, Issue:13

    Topics: Abnormalities, Multiple; Epigenesis, Genetic; Hematologic Diseases; Humans; Leukocytes, Mononuclear; Lysine; Mutation; Myosin Type I; Vestibular Diseases

2023
Identification of a KDM6A somatic mutation responsible for Kabuki syndrome by excluding a conflicting KMT2D germline variant through episignature analysis.
    European journal of medical genetics, 2023, Volume: 66, Issue:8

    Topics: Autism Spectrum Disorder; Biological Specimen Banks; Codon, Nonsense; Germ Cells; Hematologic Diseases; Histone Demethylases; Humans; Lysine; Male; Mutation; Vestibular Diseases

2023
UTX-guided neural crest function underlies craniofacial features of Kabuki syndrome.
    Proceedings of the National Academy of Sciences of the United States of America, 2017, 10-24, Volume: 114, Issue:43

    Topics: Abnormalities, Multiple; Animals; Cell Survival; Disease Models, Animal; Face; Female; Gene Expression Regulation, Developmental; HEK293 Cells; Hematologic Diseases; Histone Demethylases; Humans; Lysine; Male; Mice, Knockout; Mice, Transgenic; Mutation; Neural Crest; Nuclear Proteins; Skull; Vestibular Diseases

2017
Presynaptic GABA(B) receptors decrease neurotransmitter release in vestibular nuclei neurons during vestibular compensation.
    Neuroscience, 2012, Oct-25, Volume: 223

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Animals, Newborn; Baclofen; Chick Embryo; Excitatory Amino Acid Antagonists; GABA Agents; In Vitro Techniques; Lysine; Microscopy, Confocal; Microtubule-Associated Proteins; Neurons; Neurotransmitter Agents; Patch-Clamp Techniques; Presynaptic Terminals; Receptors, GABA-B; Sodium Channel Blockers; Statistics, Nonparametric; Synaptic Potentials; Synaptotagmin I; Synaptotagmin II; Tetrodotoxin; Time Factors; Valine; Vestibular Diseases; Vestibular Nuclei

2012